Answers are grounded in this paper and cite their sources.
Adiponectin (also named apM1, Arcp-30, AdipoQ, or GBP-28), an abundant protein produced by adipose tissue, is regarded as one of the adipokines, which include leptin, resistin, interleukin-6, tumor necrosis factor-α, and plasminogen activator inhibitor-1, and other constituents necessary for endocrinologically active adipose tissue (1)(2)(3)(4). Decreased adiponectin concentrations have been associated with the fundamental components of the metabolic syndrome (3)(4), i.e., insulin resistance and type 2 diabetes (2)(5)(6)(7)(8)(9)(10), hypertension, endothelial dysfunction (11)(12), and increased susceptibility to atherosclerosis (13)(14). Despite its intriguing associations with the metabolic syndrome, the clinical use of adiponectin as an analyte remains to be defined. In addition to early in-house methods, most recent studies have been performed with ELISA-based methods or a RIA-based commercial method by Linco Research (8). However, reports comparing the separate methods have not been published, and the introduction of a commercially available ELISA-based method could enable even wider implementation of adiponectin measurements in the implicated fields of research.
No takes yet. Share an insight, caveat, or question.
Pauli Suominen (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: